Selank
10mg
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Research has examined its anxiolytic, nootropic and immunomodulatory properties. Selank is structurally related to Semax but targets different receptor pathways, with studies indicating modulation of GABA and serotonin signalling. Commonly researched in psychopharmacology and immune function studies. Supplied as lyophilised powder, third-party tested, lab certificate published on this page.
Published research on Selank is indexed on PubMed.
Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.
98%+
Purity
LAB
Certified
SAME
Day Ship
Quantity
Add £18.01 more for free UK delivery
Damaged or lost? Free reshipment guaranteed
Cognitive Stack
Two nootropic research peptides. Semax (NACL-PGP) and Selank (TKPRPGP).
Buy Selank as part of this curated 2-vial research stack instead of separately. Same components, lower total price.
Research Use Only
This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.
Certificate of Analysis
Third-party tested
Lyophilised Stability
24 months
Sealed at -20°C, light-protected
Reconstituted Stability
Up to 3 months
Stored at 2-8°C after mixing
Cold-Chain Shipping
Always
Dry-cold pack, Royal Mail Tracked 24
Important Notice
All compounds are sold individually and do not include research supplies. Products are provided in lyophilised (powder) form and require proper reconstitution before use in research settings.
Related Products
Research Overview
Selank is a synthetic heptapeptide analogue of tuftsin, an endogenous immunomodulatory peptide derived from the Fc region of immunoglobulin G. Developed at the Institute of Molecular Genetics in Russia, Selank has been studied extensively for its anxiolytic properties, GABA system modulation, and effects on immune function. The compound is often researched alongside Semax, where Semax investigations concentrate on cognitive enhancement and BDNF modulation, Selank research focuses on anxiety reduction, stress response regulation, and GABAergic neurotransmission. Selank has been approved in Russia as a pharmaceutical treatment for generalised anxiety disorder. Research has examined its influence on serotonin and norepinephrine metabolism, its modulation of interleukin expression, and its effects on enkephalin degradation. The peptide's dual anxiolytic and immunomodulatory profile represents a unique pharmacological combination not commonly found in single-molecule compounds. Studies have documented its effects on the hypothalamic-pituitary-adrenal (HPA) axis and its ability to stabilise enkephalins in blood serum, contributing to its anxiolytic mechanism of action.
Product Specifications
Laboratory Handling
- Store lyophilised vials at -20°C. Reconstituted Selank should be refrigerated at 2-8°C and used within 4 weeks.
- Reconstitute with bacteriostatic water. Swirl gently until fully dissolved, do not shake or vortex.
- Maintain aseptic technique during handling. Sterilise vial stoppers with alcohol prior to needle insertion.
- Aliquot reconstituted peptide into single-use volumes to avoid degradation from repeated freeze-thaw cycles.
Frequently Asked Questions
Selank
10mg · £26.99